• US therapeutic: $488M (+14% QoQ, +92% YoY*) • US cosmetic: $366M (+20% QoQ, +149% YoY*) -- US total: $854M (57% therapeutic; 43% cosmetic) was 72% of worldwide total
• Ex-US therapeutic: $115M (+12 QoQ, +167% YoY*) • Ex-US cosmetic: $218M (+27% QoQ, +176% YoY*) -- Ex-US total: $333M (35% therapeutic; 65% cosmetic) was 28% of worldwide total
*YoY growth rates are exaggerated due to the effect of the pandemic during 2Q20.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.